Literature DB >> 9661012

Susceptibility of Chlamydia trachomatis to chlorhexidine gluconate gel.

M F Lampe1, L M Ballweber, W E Stamm.   

Abstract

To identify topical antimicrobial preparations which may be effective in preventing the transmission of sexually transmitted diseases, we examined the activity of chlorhexidine gluconate (CHG) against Chlamydia trachomatis. Chlamydial elementary bodies were incubated with dilutions of CHG gel for various times from 0 to 120 min. An aliquot of each dilution was further diluted and was inoculated onto McCoy cell monolayers in individual wells in a 96-well microtiter plate. The cultures were incubated for 48 h, and the chlamydial inclusions were stained and counted. CHG gel diluted fourfold (0.0625% CHG) killed C. trachomatis serovar D, and CHG gel diluted eightfold (0.0313% CHG) killed serovar F immediately upon exposure. CHG gel diluted 16-fold (0.0156% CHG) killed serovar D, and CHG gel diluted 32-fold (0.0078% CHG) killed serovar F after 120 min of exposure. Alteration of the pH over the range of from 4 to 8 did not significantly affect its activity. The addition of 10% whole human blood decreased the CHG gel activity at 0 min but had no significant effect after 120 min of exposure. We conclude that CHG gel may be effective topically against C. trachomatis at concentrations that can be used and under conditions that are found in the female genital tract and that further studies of its antimicrobial efficacy and toxicity in vivo are warranted.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9661012      PMCID: PMC105674     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Immunization against scrub typhus. II. Preparation of lyophilized living vaccine.

Authors:  E B JACKSON; J E SMADEL
Journal:  Am J Hyg       Date:  1951-05

2.  Purification on renografin density gradients of Chlamydia trachomatis grown in the yolk sac of eggs.

Authors:  L Howard; N S Orenstein; N W King
Journal:  Appl Microbiol       Date:  1974-01

Review 3.  Antibacterial activity of chlorhexidine.

Authors:  A D Russell; M J Day
Journal:  J Hosp Infect       Date:  1993-12       Impact factor: 3.926

Review 4.  A review of chlorhexidine and its use in special populations.

Authors:  M A al-Tannir; H S Goodman
Journal:  Spec Care Dentist       Date:  1994 May-Jun

5.  Reducing the risk of Chlamydia trachomatis genital tract infection by evaluating the prophylactic potential of vaginally applied chemicals.

Authors:  J M Lyons; J I Ito
Journal:  Clin Infect Dis       Date:  1995-10       Impact factor: 9.079

6.  Structural and polypeptide differences between envelopes of infective and reproductive life cycle forms of Chlamydia spp.

Authors:  T P Hatch; I Allan; J H Pearce
Journal:  J Bacteriol       Date:  1984-01       Impact factor: 3.490

7.  Detection of Chlamydia trachomatis inclusions in Mccoy cell cultures with fluorescein-conjugated monoclonal antibodies.

Authors:  W E Stamm; M Tam; M Koester; L Cles
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

8.  Susceptibility of Neisseria gonorrhoeae to protegrins.

Authors:  X D Qu; S S Harwig; A M Oren; W M Shafer; R I Lehrer
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

9.  Inhibition of growth of Chlamydia trachomatis by nonoxynol-9 in vitro.

Authors:  S Benes; W M McCormack
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

10.  In vitro activity of the spermicide nonoxynol-9 against Chlamydia trachomatis.

Authors:  J P Kelly; R B Reynolds; S Stagno; W C Louv; W J Alexander
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

View more
  10 in total

1.  Susceptibility of Chlamydia trachomatis to excipients commonly used in topical microbicide formulations.

Authors:  M F Lampe; L C Rohan; M C Skinner; W E Stamm
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

2.  An automated image-based method for rapid analysis of Chlamydia infection as a tool for screening antichlamydial agents.

Authors:  Ichie Osaka; Jeffrey M Hills; Sarah L Kieweg; Heather E Shinogle; David S Moore; P Scott Hefty
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

3.  In vitro microbicidal activities of cecropin peptides D2A21 and D4E1 and gel formulations containing 0.1 to 2% D2A21 against Chlamydia trachomatis.

Authors:  L M Ballweber; J E Jaynes; W E Stamm; M F Lampe
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

4.  Killing of Chlamydia trachomatis by novel antimicrobial lipids adapted from compounds in human breast milk.

Authors:  M F Lampe; L M Ballweber; C E Isaacs; D L Patton; W E Stamm
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

5.  Hydrogels containing monocaprin have potent microbicidal activities against sexually transmitted viruses and bacteria in vitro.

Authors:  H Thormar; G Bergsson; E Gunnarsson; G Georgsson; M Witvrouw; O Steingrímsson; E De Clercq; T Kristmundsdóttir
Journal:  Sex Transm Infect       Date:  1999-06       Impact factor: 3.519

6.  In vitro inhibitory effects of hinokitiol on proliferation of Chlamydia trachomatis.

Authors:  Hiroaki Yamano; Tsutomu Yamazaki; Kozue Sato; Sadashi Shiga; Toshikatsu Hagiwara; Kazunobu Ouchi; Toshio Kishimoto
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

7.  Biosynthesized tea polyphenols inactivate Chlamydia trachomatis in vitro.

Authors:  Tsutomu Yamazaki; Toshio Kishimoto; Sadashi Shiga; Kozue Sato; Toshikatsu Hagiwara; Miyuki Inoue; Nozomu Sasaki; Kazunobu Ouchi; Yukihiko Hara
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

8.  Inhibition of chlamydial infection in the genital tract of female mice by topical application of a peptide deformylase inhibitor.

Authors:  Amit Balakrishnan; Lingling Wang; Xiaojin Li; Pamela Ohman-Strickland; Paul Malatesta; Huizhou Fan
Journal:  Microbiol Res       Date:  2007-10-23       Impact factor: 5.415

9.  Lipopolysaccharide-binding alkylpolyamine DS-96 inhibits Chlamydia trachomatis infection by blocking attachment and entry.

Authors:  Ichie Osaka; P Scott Hefty
Journal:  Antimicrob Agents Chemother       Date:  2014-03-24       Impact factor: 5.191

10.  Does human saliva decrease the antimicrobial activity of chlorhexidine against oral bacteria?

Authors:  Thaer Abouassi; Christian Hannig; Katja Mahncke; Lamprini Karygianni; Martin Wolkewitz; Elmar Hellwig; Ali Al-Ahmad
Journal:  BMC Res Notes       Date:  2014-10-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.